Browse by Poster Presenter

Type here to filter the list

B
Baak, Brenda

Boston Collaborative Drug Surveillance Program
(P-242) Nsaids and Risk of Myocardial Infarction in Patients with No Major Risk Factors: A Nested Case-control Study in the UK Clinical Practice Research Datalink
Brenda Baak
Favorite
Baas, Gert

SIR Institute
(P-198) Pharmacist-led Intervention to Support Deprescribing of Cardiometabolic Medication Among People with Type 2 Diabetes: A Pilot Study
Gert Baas
Favorite
Bacon, Seb

University of Oxford
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Seb Bacon
Favorite
Badier, Laure
(P-436) Review of Sytemic Adverse Drug Reactions of Vascular Endothelial Growth Factor Inhibitors in French Pharmacovigilance Data Base
Laure Badier
Favorite
Bae, Green

Ewha Womans University
(P-346) Periodic Safety Reporting System for Post-market Drug Safety: A Comparative Analysis of Europe, United States, Japan and Korea
Green Bae
Favorite
Bae, Jungjun

University of Kentucky
(P-027) Four Competing Definitions of Morphine Equivalence Insidiously Inhibit Evidence Synthesis
Jungjun Bae
Favorite
(P-485) Predictors of Concomitant Use of Opioids and Gabapentin in the National Alzheimer's Coordinating Center Database
Jungjun Bae
Favorite
Baek, Yeon-Hee

Sungkunkwan University
(P-533) PD-1 Immune Checkpoint Inhibitors and Serious Immune-related Adverse Events
Yeon-Hee Baek
Favorite
Bae, Sang-Cheol

Hanyang University Hospital for Rheumatic Diseases
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Sang-Cheol Bae
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Sang-Cheol Bae
Favorite
Bagheri, Haleh

Service de Pharmacologie Médicale et Clinique. Centre de Pharmacovigilance et de Pharmacoépidémiologie. Faculté de Médecine.
(P-436) Review of Sytemic Adverse Drug Reactions of Vascular Endothelial Growth Factor Inhibitors in French Pharmacovigilance Data Base
Haleh Bagheri
Favorite
Bahar, Ayfer

Department of Medical Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey
(P-489) Evaluation of Chirality for Withdrawn Drugs
Ayfer Bahar
Favorite
Bak, Daniel

US Food and Drug Administration
(P-549) Benzodiazepine Use, Nonmedical Use, and Overdose in the U.S
Daniel Bak
Favorite
Bakshi, Anirudh

McGill Dept of Epidemiology, Biostatistics and Occupational Health
(P-260) The Effect of Aspirin on COPD: A Methodological Review of the Observational Studies
Anirudh Bakshi
Favorite
Balabanova, Yanina

Bayer AG
(P-065) Safety of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism
Yanina Balabanova
Favorite
(P-250) Lessons from a Post-authorisation Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Practice in Four Countries
Yanina Balabanova
Favorite
(P-252) Safety and Effectiveness of Rivaroxaban in First-time Users with Non-valvular Atrial Fibrillation in Routine Practice
Yanina Balabanova
Favorite
(P-314) Time Trends in Patient Characteristics of New Rivaroxaban (RVX) Users with Atrial Fibrillation (AF) Across Four Countries
Yanina Balabanova
Favorite
Balasubramanian, Akhila

Center for Observational Research, Amgen
(P-075) Visualization Methods to Examine Treatment Patterns in Pharmacoepidemiology: An Example Using Osteoporosis Medications
Akhila Balasubramanian
Favorite
(P-573) Using Negative Control Outcomes to Assess the Comparability of Treatment Groups Among Postmenopausal Women Switching Osteoporosis Therapy
Akhila Balasubramanian
Favorite
Bang, Minyoung

Korea Institute of Drug Safety & Risk Management
(P-323) Risk of Cardiovascular Diseases Associated with Sulfonylurea as an Add-on Therapy to Metformin in Patients with Type 2 Diabetes Mellitus
Minyoung Bang
Favorite
Baniecki, Mary Lynn

Pfizer Inc
(P-018) Clinical Characteristics and Biomarkers of sars-cov-2 Infection in Patients Treated with Remdesivir in Hospital - A Population Based Cohort Study
Mary Lynn Baniecki
Favorite
Bansal, Parveen

University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, Punjab, India- 151203
(P-184) Prevalence and Predictors of Potentially Inappropriate Psychotropic (PIP) Medications in Older Adults with Psychiatric Illness
Parveen Bansal
Favorite
(P-185) Prevalence of Potentially Inappropriate Medication and Its Correlates in Elderly Hospitalized Patients: A Cross‑sectional Study Based on Beers Criteria
Parveen Bansal
Favorite
(P-186) Prevalence of Potentially Inappropriate Medication in Elderly Inpatients with Chronic Kidney Disease (CKD)
Parveen Bansal
Favorite
Barany, Peter

Karolinska Institutet
(P-618) Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
Peter Barany
Favorite
Barbato, Angelo

Unit for Quality of Care and Rights Promotion in Mental Health, Istituto di Ricerche Farmacologiche Mario IRCCS
(P-480) From Contact Coverage to Effective Coverage of Community Care for Patients with Severe Mental Disorders: A Real-world Investigation from Italy
Angelo Barbato
Favorite
Barberato Filho, Silvio

University of Sorocaba
(P-412) Antimicrobial Resistance in Endodontic Infections in Latin America (MICROBE-DENT): Systematic Review
Silvio Barberato Filho
Favorite
Barberato-Filho, Silvio

University of Sorocaba
(P-459) Efficacy and Effectiveness of Mobile Health Technologies to Improve Breastfeeding: Scoping Review
Silvio Barberato-Filho
Favorite
Barbieri, Sebastiano

Centre for Big Data Research in Health, UNSW Sydney, Sydney, Australia
(P-326) The Effect of Prescriber, Treatment, and Client Characteristics on Retention in Opioid Agonist Treatment: A 15-year Retrospective Cohort Study
Sebastiano Barbieri
Favorite
Barkun, Alan

Division of Gastroenterology, McGill University Health Centre, Montreal, Canada
(P-617) Use of Renin-angiotensin-aldosterone System Inhibitors and the Risk of Acute Pancreatitis
Alan Barkun
Favorite
Barnes, Edward

Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
(P-289) Drug-induced Liver Injury Associated with Lopinavir-ritonavir in Patients with COVID-19: A Disproportionality Analysis of U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) Data
Edward Barnes
Favorite
Barnes, Geoffrey

University of Michigan
(P-633) Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Valvular Atrial Fibrillation: A Population-based Cohort Study
Geoffrey Barnes
Favorite
Barrachina-Bonet, Laia

Fundació per al Foment de la Investigació Sanitaria i Biomédica de la Comunitat Valenciana (FISABIO)
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Laia Barrachina-Bonet
Favorite
Barreto, Jéssica

Federal University of Espirito Santo
(P-394) Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
Jéssica Barreto
Favorite
Barthelmes, J

Janssen-Cilag Limited, High Wycombe, United Kingdom
(P-377) Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
J Barthelmes
Favorite
Bartolini, Claudia

ARS Toscana
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Claudia Bartolini
Favorite
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Claudia Bartolini
Favorite
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Claudia Bartolini
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Claudia Bartolini
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Claudia Bartolini
Favorite
(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
Claudia Bartolini
Favorite
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Claudia Bartolini
Favorite
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Claudia Bartolini
Favorite
Bassel, Marielle

Evidera
(P-103) Methodologic Challenges and Considerations for the Collection of Dietary Intake Data in Real-world Populations
Marielle Bassel
Favorite
Bate, Andrew

GlaxoSmithKline
(P-505) Automating Individual Case Safety Report Identification Within Scientific Literature Using Natural Language Processing
Andrew Bate
Favorite
Bates, Chris

The Phoenix Partnership
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Chris Bates
Favorite
Baud, David

Materno-Fetal and Obstetrics Research Unit, Department “Woman-Mother-Child”, Lausanne University Hospital, Lausanne, Switzerland
(P-475) Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
David Baud
Favorite
Bauer-Mehren, Anna

Data Science, Pharmaceutical Research and Early Development Informatics (pREDi), Roche Innovation Center Munich (RICM), Penzberg, Germany
(P-521) Towards OS approximation in early clinical trials using Prognostic Scores
Anna Bauer-Mehren
Favorite
Baygul, Arzu

Koç University School of Medicine
(P-448) Nsaids and Paracetamol-induced Hepatotoxicity: A Systematic Review and Meta-analysis of Observational Studies
Arzu Baygul
Favorite
Bazelier, Marloes

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands
(P-360) Monitoring of Adverse Drug Reaction-related Parameters in Children, Youth and Young Adults Prescribed Antipsychotic Drugs by General Practitioners
Marloes Bazelier
Favorite
Bea, Sungho

School of Pharmacy, Sungkyunkwan University
(P-089) Clinical and Cost-saving Effects of the Drug Utilization Review Modernization Pilot Project in Inpatient and Outpatient Settings in Korea
Sungho Bea
Favorite
Beau, Anna-Belle

CHU Toulouse, Université de Toulouse, INSERM, CERPOP: SPHERE, Toulouse
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Anna-Belle Beau
Favorite
Beck-Cantin, Marie-Françoise

Reims university hospital
(P-308) Penetration Rate of Anti-tnf Biosimilars in Hospitals in France: 5 Years Status
Marie-Françoise Beck-Cantin
Favorite
Becker, Claudia

University of Basel
(P-003) Incidence Rates (IR) and IR Ratios of Alzheimer’s Disease in Patients with Cataract Compared to the General Population: Analyses Using the Clinical Practice Research Datalink (CPRD)
Claudia Becker
Favorite
Becker, Tim

Data Science, Pharmaceutical Research and Early Development Informatics (pREDi), Roche Innovation Center Munich (RICM), Penzberg, Germany
(P-521) Towards OS approximation in early clinical trials using Prognostic Scores
Tim Becker
Favorite
Bedene, Ajda

Leiden University Medical Center
(P-010) Slovenia versus the Netherlands: A Comparison of Opioid Prescription Strategies
Ajda Bedene
Favorite
Behling, Mike

OM1, Inc.
(P-481) Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large Us-based Real-world Cohort
Mike Behling
Favorite
Behr, Sigrid

Novartis Pharma AG
(P-050) Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results
Sigrid Behr
Favorite
(P-428) Incidence of Angioedema After Initiation of Angiotensin-converting Enzyme Inhibitors in Adults with Heart Failure
Sigrid Behr
Favorite
Belhassen, Manon

PELyon, Pharmacoepidemiology Lyon
(P-337) E-CORE - Setting up a European Network for Real World COVID-19 Studies
Manon Belhassen
Favorite
Bellan, Cristiana

Università degli studi di Siena, Siena
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Cristiana Bellan
Favorite
Benard-Laribiere, Anne

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France
(P-002) Risk of First Ischemic Stroke and Use of Antidopaminergic Antiemetics: A Case-time-control Study in France
Anne Benard-Laribiere
Favorite
Benemei, Silvia

Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy
(P-472) Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy
Silvia Benemei
Favorite
Benevent, Justine

Service de Pharmacologie Médicale et Clinique. Centre de Pharmacovigilance et de Pharmacoépidémiologie. Faculté de Médecine.
(P-238) Risk of Domperidone in Pregnant Women: A Study in the EFEMERIS Database
Justine Benevent
Favorite
(P-436) Review of Sytemic Adverse Drug Reactions of Vascular Endothelial Growth Factor Inhibitors in French Pharmacovigilance Data Base
Justine Benevent
Favorite
Bennison, Craig

Pharmerit – an OPEN Health Company
(P-285) Global Symptom Improvement for Patients with Aromatic L-amino Acid Decarboxylase Deficiency Using Individual Participant Data
Craig Bennison
Favorite
Bentley, John

The University of Mississippi
(P-402) Polypharmacy and Health-related Quality of Life in Older Adults with Cancer: Determining Breakpoints
John Bentley
Favorite
Beren, Ian

WorkPartners, LLC
(P-216) Prevalence and Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Diabetes
Ian Beren
Favorite
(P-217) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Bone Diseases
Ian Beren
Favorite
(P-218) Trends in Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Back Pain
Ian Beren
Favorite
(P-219) Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Osteoarthritis
Ian Beren
Favorite
(P-220) Absence Benefit Use and Payment Trends Among Short- and Long-term Disability, and Workers' Compensation for Employees with Any of 20 Top Agency for Healthcare Research and Quality Conditions
Ian Beren
Favorite
(P-221) Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Rheumatoid Arthritis
Ian Beren
Favorite
(P-222) Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Mental Disorders in the United States
Ian Beren
Favorite
(P-223) Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Substance Abuse Mental Disorders in the United States
Ian Beren
Favorite
(P-224) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Systemic Lupus Erythematosus or Connective Tissue Disorders in the United States
Ian Beren
Favorite
(P-225) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States
Ian Beren
Favorite
(P-226) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Gastrointestinal (Digestive System) Conditions in the United States
Ian Beren
Favorite
(P-227) Absence Benefit Utilization, Duration of Leaves, and Payments Vary by Benefit and over Time for Short- and Long-term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States
Ian Beren
Favorite
(P-228) Trends from 2001 to 2019 in Workers Compensation Indemnity Payments and Absences Among Employees with Bone Diseases, Headaches/migraines, Diabetes, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis and Back Pain
Ian Beren
Favorite
Bergamaschi Motta, Cristiane de Cassia

University of Sorocaba
(P-412) Antimicrobial Resistance in Endodontic Infections in Latin America (MICROBE-DENT): Systematic Review
Cristiane de Cassia Bergamaschi Motta
Favorite
(P-459) Efficacy and Effectiveness of Mobile Health Technologies to Improve Breastfeeding: Scoping Review
Cristiane de Cassia Bergamaschi Motta
Favorite
Berhane, Araia

Department of Public Health, Ministry of Health
(P-411) Effectiveness of a Six-month Isoniazid as Tuberculosis Preventive Therapy in People Living with HIV in Eritrea: A Retrospective Cohort Study
Araia Berhane
Favorite
Berkovitch, Matitiahu

2Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh), Zerifin, Sackler Faculty of Medicine, Tel-Aviv Universit
(P-168) Systematic Review and Meta-analysis: Efficacy and Safety of Medical Cannabis in Children
Matitiahu Berkovitch
Favorite
Bernatsky, Sasha

McGill University Health Centre
(P-524) Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis
Sasha Bernatsky
Favorite
(P-525) Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
Sasha Bernatsky
Favorite
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Sasha Bernatsky
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Sasha Bernatsky
Favorite
Bernelot Moens, Hein

Stichting Arthritis Research and Collaboration Hub (ARCH)
(P-515) Factors Predictive of Treatment Success of Novel Disease-modifying Anti-rheumatic Drugs (DMARDS) in Patients with Inflammatory Arthritis
Hein Bernelot Moens
Favorite
Bertani, Lorenzo

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Lorenzo Bertani
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Lorenzo Bertani
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Lorenzo Bertani
Favorite
Bertoia, Monica

Optum Epidemiology
(P-554) Identification of Patients with Nonalcoholic Steatohepatitis (NASH) in an Electronic Health Record (EHR) Database
Monica Bertoia
Favorite
(P-555) The Utility of Non-specific ICD-10 Z3A Codes in Estimating Gestational Age
Monica Bertoia
Favorite
Bertrand, Marion

EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
(P-471) Intravitreal Anti-vascular Endothelial Growth Factors Use in France: Cross-sectional and Longitudinal Nationwide Observational Studies
Marion Bertrand
Favorite
Besag PhD, Frank

Research Department of Practice and Policy, UCL School of Pharmacy
(P-579) Prenatal Exposure to Psychotropic Medications and the Risk of Seizure in Children: A Population-based Cohort Study
Frank Besag PhD
Favorite
Bezin, Julien

University of Bordeaux
(P-002) Risk of First Ischemic Stroke and Use of Antidopaminergic Antiemetics: A Case-time-control Study in France
Julien Bezin
Favorite
(P-178) Patterns of Antihypertensive Drugs Use After Primary Stroke in the General Population
Julien Bezin
Favorite
Bhagavathula, Akshaya S

Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, 12000 Prague, Czech Republic
(P-187) Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-sectional Study
Akshaya S Bhagavathula
Favorite
Bhagwandass, Hemita

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(P-107) Evaluating the Use of Prescription Sequence Symmetry Analysis as a Pharmacovigilance Tool: A Scoping Review
Hemita Bhagwandass
Favorite
Bharat, Chrianna

University of New South Wales
(P-326) The Effect of Prescriber, Treatment, and Client Characteristics on Retention in Opioid Agonist Treatment: A 15-year Retrospective Cohort Study
Chrianna Bharat
Favorite
Bhaskaran, Krishnan

London School of Hygiene and Tropical Medicine
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Krishnan Bhaskaran
Favorite
Bhupathi, Vasudev

Alkermes, Inc.
(P-313) Utilizing a Structured Benefit-risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder
Vasudev Bhupathi
Favorite
Bignon, Emmnuelle

Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000 Bordeaux, France
(P-575) Impact of Treatment Sequence on Survival Outcome in Patients with a Second Treatment Line for Metastatic Castration-resistant Prostate Cancer: A New-user Design in the French Nationwide Claims Database
Emmnuelle Bignon
Favorite
Billioti de Gage, Sophie

French National Agency for Medicines and Health Products Safety
(P-471) Intravitreal Anti-vascular Endothelial Growth Factors Use in France: Cross-sectional and Longitudinal Nationwide Observational Studies
Sophie Billioti de Gage
Favorite
Björck, Staffan

Centre of Registers Västra Götaland, Gothenburg, Sweden
(P-371) Swedish covid-19 Investigation for Future Insights – a Population Epidemiology Approach Using Register Linkage (SCIFI- PEARL)
Staffan Björck
Favorite
Bjelica, Jovana

Integrated Information System Implementation Board at the Clinical Center of Serbia
(P-337) E-CORE - Setting up a European Network for Real World COVID-19 Studies
Jovana Bjelica
Favorite
Blackburn, Stella

Iqvia
(P-596) Insights from a Review of Publicly Available Information on Post Authorisation Safety Studies (PASS)
Stella Blackburn
Favorite
Black, Steve

Brighton Collaboration, Task Force for Global Health
(P-205) Use and Performance of Brighton Collaboration Case Definitions in Low-middle Income Settings
Steve Black
Favorite
Black, Wynona

Merck & Co. Inc
(P-493) Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States
Wynona Black
Favorite
Blais, Claudia

Institut national de sante publique du Quebec
(P-244) Polypharmacy Among Older Individuals with Heart Failure: Trends Between 2000 and 2017 in the Province of Quebec, Canada
Claudia Blais
Favorite
Blais, Joseph

the University of Hong Kong
(P-291) Global Antiplatelet Sales Trend: A Focus on P2Y12 Inhibitors from 2008 to 2018
Joseph Blais
Favorite
Blake, Kathryn

Center for Pharmacogenomics and Translational Research, Nemours Children’s Specialty Care
(P-241) Assessment of Health-related Quality of Life in Adults with Asthma by Asthma Severity
Kathryn Blake
Favorite
Blandizzi, Corrado

Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa; Unit of Adverse Drug Reactions Monitoring, University Hospital of Pisa, Pisa, Italy
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Corrado Blandizzi
Favorite
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Corrado Blandizzi
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Corrado Blandizzi
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Corrado Blandizzi
Favorite
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Corrado Blandizzi
Favorite
Bliddal, Mette

University of Southern Denmark (Department of Clinical Research)
(P-564) Melatonin Use Among Children, Adolescents, and Young Adults. a Danish Nationwide Drug Utilization Study
Mette Bliddal
Favorite
Blin, Patrick

Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000 Bordeaux, France
(P-575) Impact of Treatment Sequence on Survival Outcome in Patients with a Second Treatment Line for Metastatic Castration-resistant Prostate Cancer: A New-user Design in the French Nationwide Claims Database
Patrick Blin
Favorite
Bloomgren, Gary

Alkermes, Inc.
(P-312) Disease Prevalence, Comorbidities, and Medication Utilization Among Patients with Opioid Use Disorder in the US
Gary Bloomgren
Favorite
Blozik, MD, MPH, Eva

Department of Health Sciences, Helsana Insurance Group, Zurich, Switzerland
(P-475) Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
Eva Blozik, MD, MPH
Favorite
Blyth, Fiona

School of Public Health, Faculty of Medicine and Health University of Sydney
(P-327) POPPY II Cohort Profile– a Population-based Linked Cohort Examining the Course and Outcomes of Prescription Opioid Use in NSW, Australia, 2003-2018
Fiona Blyth
Favorite
Boivin, Jean-Francois

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
(P-585) Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation
Jean-Francois Boivin
Favorite
Bolibar, Bonaventura

Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona , Spain
(P-567) SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
Bonaventura Bolibar
Favorite
Bonfanti, Rachel

UBC
(P-206) Pediatric Fentanyl Overdose Within an Electronic Health Record Database
Rachel Bonfanti
Favorite
Boose-Sheppard, Sharon

Genentech, Inc.
(P-056) Genetic Heterogeneity Patterns of Electronic Medical Record (EMR)-Derived Race Groups in a Deidentified Clinico-genomic Database (CGDB)
Sharon Boose-Sheppard
Favorite
Boren, Macy

College of Pharmacy, University of Florida
(P-066) Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data
Macy Boren
Favorite
Borse, Rebekah

Merck & Co., Inc.,
(P-275) A Systematic Literature Review of the Epidemiology, Health-related Quality of Life and Economic Burden, Including Disease Pathways and Treatment Patterns of Relapsed/refractory Classical Hodgkin Lymphoma
Rebekah Borse
Favorite
(P-276) Clinical Outcomes Among Relapsed/refractory (R/R) Adult and Pediatric Classical Hodgkin’s Lymphoma (cHL) Patients: A Global Systematic Literature Review (SLR)
Rebekah Borse
Favorite
(P-277) An Updated Structured Review of the Epidemiology, Guidelines, and Real-world Treatment Patterns for Relapsed/refractory Primary Mediastinal Large B-cell Lymphoma
Rebekah Borse
Favorite
Borsi, Andras

Janssen-Cilag Limited, High Wycombe, United Kingdom
(P-377) Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
Andras Borsi
Favorite
Bortnichak, Edward

Merck & Co., Inc.
(P-321) Epidemiology of Treatment Resistant Depression in the US
Edward Bortnichak
Favorite
(P-493) Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States
Edward Bortnichak
Favorite
(P-569) Comorbidities Associated with Insomnia Stratified by Age and Sex
Edward Bortnichak
Favorite
Bosco, Jaclyn

IQVIA, Real World Solutions
(P-596) Insights from a Review of Publicly Available Information on Post Authorisation Safety Studies (PASS)
Jaclyn Bosco
Favorite
Bosi, Alessandro

Karolinska Institutet
(P-618) Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
Alessandro Bosi
Favorite
Bouvy, Marcel

University of Utrecht
(P-198) Pharmacist-led Intervention to Support Deprescribing of Cardiometabolic Medication Among People with Type 2 Diabetes: A Pilot Study
Marcel Bouvy
Favorite
Bowler, Timothy

Regeneron Pharmaceuticals, Inc., Tarrytown, NY
(P-574) Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
Timothy Bowler
Favorite
Boyce, Richard

University of Pittsburgh
(P-265) Detecting Tizanidine and cyp1a2 Inhibitor Interaction Signals Using the Food and Drug Administration’s Adverse Event Reporting System
Richard Boyce
Favorite
Bo, Zhenyan

Department of Pharmacy, West China Second University Hospital, Sichuan University
(P-079) Safety of Propofol Use in Children and Adolescents: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS)
Zhenyan Bo
Favorite
Bradbury, Brian

Center for Observational Research, Amgen
(P-573) Using Negative Control Outcomes to Assess the Comparability of Treatment Groups Among Postmenopausal Women Switching Osteoporosis Therapy
Brian Bradbury
Favorite
Bradley, Marie

Division of Epidemiology, Office of Surveillance and epidemiology,Center for Drug Evaluation and Research, US Food and Drug Administration
(P-280) Temporal Trends in Medication Utilization Among Hospitalized COVID-19 Patients
Marie Bradley
Favorite
(P-281) Examining the Evolving Pandemic: Trends in COVID-19 Severity for Hospitalized COVID-19 Patients over Time
Marie Bradley
Favorite
Braitmaier, Malte

Leibniz Institute for Prevention Research and Epidemiology – BIPS
(P-026) Assessment of Predictors of Fractures in German Older Adults Using a Large Population Sample
Malte Braitmaier
Favorite
Brand�o, Nat�lia

SUS Collaborating Centre for Technology Assessment and Excellence in Health
(P-096) Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
Nat�lia Brand�o
Favorite
(P-394) Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
Nat�lia Brand�o
Favorite
Brandt, Lena

Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden
(P-257) The Use of Uncertain Exposure – a Method to Define switching and Add-on in Pharmacoepidemiology
Lena Brandt
Favorite
Brauer PhD, Ruth

Research Department of Practice and Policy, UCL School of Pharmacy
(P-579) Prenatal Exposure to Psychotropic Medications and the Risk of Seizure in Children: A Population-based Cohort Study
Ruth Brauer PhD
Favorite
Bravata, Ivana

Janssen-Cilag S.p.A., Milan, Italy
(P-377) Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
Ivana Bravata
Favorite
Brecht, Tom

OM1, Inc.
(P-481) Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large Us-based Real-world Cohort
Tom Brecht
Favorite
Brendle, Madeline

University of Utah
(P-264) Evaluation of Esketamine Adverse Event from the FAERS Database and Published Case Reports
Madeline Brendle
Favorite
Breteler, Monique Maria Bernadette

Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
(P-080) Validation of Self-reported Medication Use Applying Untargeted Mass Spectrometry-based Metabolomics Techniques in the Rhineland Study
Monique Maria Bernadette Breteler
Favorite
Brett, Neil

Evidera
(P-103) Methodologic Challenges and Considerations for the Collection of Dietary Intake Data in Real-world Populations
Neil Brett
Favorite
Brewer, Iris

PRECISIONheor
(P-276) Clinical Outcomes Among Relapsed/refractory (R/R) Adult and Pediatric Classical Hodgkin’s Lymphoma (cHL) Patients: A Global Systematic Literature Review (SLR)
Iris Brewer
Favorite
Brinkley, Emma

IQVIA
(P-508) COVID-19 Symptom Severity Among Smokers: Insights from a Direct-to-community Registry
Emma Brinkley
Favorite
Brobert, Gunnar

Bayer AB
(P-065) Safety of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism
Gunnar Brobert
Favorite
(P-250) Lessons from a Post-authorisation Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Practice in Four Countries
Gunnar Brobert
Favorite
(P-252) Safety and Effectiveness of Rivaroxaban in First-time Users with Non-valvular Atrial Fibrillation in Routine Practice
Gunnar Brobert
Favorite
(P-314) Time Trends in Patient Characteristics of New Rivaroxaban (RVX) Users with Atrial Fibrillation (AF) Across Four Countries
Gunnar Brobert
Favorite
Brohawn, Philip

AstraZeneca, Gaithersburg, MD
(P-234) Molecular Epidemiology Study of Interferon Gamma (IFN-γ) Expression in Urothelial Bladder Cancer (UBC)
Philip Brohawn
Favorite
Brookhart, M. Alan

NoviSci, Inc.
(P-075) Visualization Methods to Examine Treatment Patterns in Pharmacoepidemiology: An Example Using Osteoporosis Medications
M. Alan Brookhart
Favorite
(P-573) Using Negative Control Outcomes to Assess the Comparability of Treatment Groups Among Postmenopausal Women Switching Osteoporosis Therapy
M. Alan Brookhart
Favorite
Brook, Richard

Better Health Worldwide, Inc
(P-216) Prevalence and Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Diabetes
Richard Brook
Favorite
(P-217) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Bone Diseases
Richard Brook
Favorite
(P-218) Trends in Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Back Pain
Richard Brook
Favorite
(P-219) Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Osteoarthritis
Richard Brook
Favorite
(P-220) Absence Benefit Use and Payment Trends Among Short- and Long-term Disability, and Workers' Compensation for Employees with Any of 20 Top Agency for Healthcare Research and Quality Conditions
Richard Brook
Favorite
(P-221) Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Rheumatoid Arthritis
Richard Brook
Favorite
(P-222) Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Mental Disorders in the United States
Richard Brook
Favorite
(P-223) Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Substance Abuse Mental Disorders in the United States
Richard Brook
Favorite
(P-224) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Systemic Lupus Erythematosus or Connective Tissue Disorders in the United States
Richard Brook
Favorite
(P-225) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States
Richard Brook
Favorite
(P-226) Long- and Short-term Disability and Workers' Compensation Trends for Employees with Gastrointestinal (Digestive System) Conditions in the United States
Richard Brook
Favorite
(P-227) Absence Benefit Utilization, Duration of Leaves, and Payments Vary by Benefit and over Time for Short- and Long-term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States
Richard Brook
Favorite
(P-228) Trends from 2001 to 2019 in Workers Compensation Indemnity Payments and Absences Among Employees with Bone Diseases, Headaches/migraines, Diabetes, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis and Back Pain
Richard Brook
Favorite
Brooks, Maria M

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh
(P-288) Novel Glucose-lowering Agents and Cardiorenal Benefits: Absence of Racial/ethnic Diversity in Clinical Trials
Maria M Brooks
Favorite
Brophy, James

Department of Medicine, McGill University, Montreal, Canada
(P-529) Treatment Trajectory of Antihypertensive Drugs in UK Primary Care Practices
James Brophy
Favorite
(P-585) Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation
James Brophy
Favorite
Brophy, Robert

Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri
(P-348) Study Validity in Sports Medicine: A Quantitative Assessment of Orthopedic Research Based on Publicly-obtained Data
Robert Brophy
Favorite
Brouilette, Marie-Josée

McGill University
(P-539) The Association Between Trajectories of Use of Systemic Agents and Depression in Patients with Psoriasis: A Sequence and Cluster Analysis
Marie-Josée Brouilette
Favorite
Brown, Jeffrey S.

Harvard Pilgrim Health Care Institute and Harvard Medical School
(P-050) Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results
Jeffrey S. Brown
Favorite
(P-192) Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a Population with Osteoarthritis
Jeffrey S. Brown
Favorite
(P-563) A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
Jeffrey S. Brown
Favorite
Brown, Jeremy

London School of Hygiene and Tropical Medicine
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Jeremy Brown
Favorite
Brown, John R

University of Kentucky
(P-347) Variation Among Pharmacists in Calculating Days’ Supply
John R Brown
Favorite
Brown, Joshua D

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(P-066) Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data
Joshua D Brown
Favorite
(P-101) A Pharmacovigilance Analysis of Restless Legs Syndrome Treatments and Suicidality
Joshua D Brown
Favorite
(P-320) Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting, 2006-2016
Joshua D Brown
Favorite
Brown, Mark T.

Pfizer Inc.
(P-192) Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a Population with Osteoarthritis
Mark T. Brown
Favorite
Brown, Matthew

Department of Pharmacy, University of Alabama at Birmingham Hospital
(P-430) Chronic Obstructive Pulmonary Disease and Drug-resistant Pseudomonas in Patients Hospitalized with Community-acquired Bacterial Pneumonia
Matthew Brown
Favorite
Brown, Patrick

2. University of Amsterdam, Amsterdam, the Netherlands
(P-618) Using Structural Topic Modelling to Reveal Patterns in Reports on Opioid Drugs in a Pharmacovigilance Database
Patrick Brown
Favorite
Brubaker, Scott

CBER, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
(P-060) Post-keratoplasty Fungal Keratitis in the Sentinel Distributed Database: Prevalence and Time Trends
Scott Brubaker
Favorite
Bruce, Ian

University of Manchester
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Ian Bruce
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Ian Bruce
Favorite
Bruno, Claudia

Centre for Big Data Research in Health, UNSW Sydney
(P-527) Evaluating the Impact of New Prescribing Restrictions for Publicy-subsidised Proton Pump Inhibitors in Australia: An Interrupted Time Series Analysis
Claudia Bruno
Favorite
Brusselle, Guy

Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
(P-256) Real-world Treatment Patterns of Newly Diagnosed Patients with Asthma And/or COPD
Guy Brusselle
Favorite
Bryant, Allison

OM1
(P-481) Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large Us-based Real-world Cohort
Allison Bryant
Favorite
Brynningsen, Peter K

Department of Geriatrics, Aarhus University Hospital, Palle Juul Jensens Boulevard 165, DK-8200 Aarhus N, Denmark
(P-558) Development and Validation of a Prediction Model for Mortality in Patients with Hip Fracture: Population-based Cohort Study
Peter K Brynningsen
Favorite
Buckley, Nicholas

Biomedical Informatics and Digital Health, University of Sydney
(P-527) Evaluating the Impact of New Prescribing Restrictions for Publicy-subsidised Proton Pump Inhibitors in Australia: An Interrupted Time Series Analysis
Nicholas Buckley
Favorite
Buesch, Katharina

PTC Therapeuticsw
(P-285) Global Symptom Improvement for Patients with Aromatic L-amino Acid Decarboxylase Deficiency Using Individual Participant Data
Katharina Buesch
Favorite
Buizen, Luke

National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
(P-327) POPPY II Cohort Profile– a Population-based Linked Cohort Examining the Course and Outcomes of Prescription Opioid Use in NSW, Australia, 2003-2018
Luke Buizen
Favorite
Bunner, Scott

Optum
(P-522) Early Parkinson’s Disease: Association of Baseline Fatigue, Pain and Sleep Disorders with Disease Progression
Scott Bunner
Favorite
Burcu, Mehmet

Merck & Co., Inc.
(P-270) Real-world Algorithms in Defining Castration Resistant Prostate Cancer in Retrospective Observational Studies
Mehmet Burcu
Favorite
Burden, Andrea

ETH Zurich
(P-095) Fracture Outcome Coding in Observational Osteoporosis Drug Effects Studies: A Scoping Review
Andrea Burden
Favorite
(P-115) Comparison of Rheumatic Patients Across Body Mass Index Categories
Andrea Burden
Favorite
(P-380) Comparison of 21-year Sex-specific Fracture Incidence Rates Between Type 1 and Type 2 Diabetics and Non-diabetics in Denmark (1997 – 2017)
Andrea Burden
Favorite
(P-381) Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Andrea Burden
Favorite
Burger, Johanita

North-West University
(P-011) Drug Utilization Research in Africa: overview of Demographic and Socioeconomic Profile, Health Systems and Epidemiology
Johanita Burger
Favorite
(P-162) Key Opportunities and Future Direction for Drug Utilization Research in Africa
Johanita Burger
Favorite
(P-387) Individual Case Safety Reports Analysis for Patients with Diabetes Mellitus on Insulin in Africa and the Middle East
Johanita Burger
Favorite
Burge, Russel

Eli Lilly and Company
(P-421) Inadequate Response Rates and Associated Factors to Psoriasis Therapies Using a Claims-based Algorithm
Russel Burge
Favorite
Burkard, Theresa

ETH Zurich
(P-115) Comparison of Rheumatic Patients Across Body Mass Index Categories
Theresa Burkard
Favorite
Burk, Jillian

1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
(P-563) A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
Jillian Burk
Favorite
(P-629) How Under-coded Is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data
Jillian Burk
Favorite
Burn, Edward

Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom
(P-256) Real-world Treatment Patterns of Newly Diagnosed Patients with Asthma And/or COPD
Edward Burn
Favorite
Burudpakdee, Chakkarin

IQVIA
(P-392) Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) Initiating Nintedanib or Pirfenidone Treatment Compared with Untreated Patients in the US
Chakkarin Burudpakdee
Favorite
Bushnell, Greta

Rutgers Center for Pharmacoepidemiology and Treatment Science
(P-350) Overdose Risk Following Prescription Benzodiazepine Treatment in Young People
Greta Bushnell
Favorite
Butler, Harris

University of Colorado Anschutz Medical Campus
(P-213) Surveillance of Postmarketing Risk-mitigation Behavior Using Tests of Model Misspecification in a Statistical Process Control Framework
Harris Butler
Favorite
Butte, Atul

1. Bakar Computational Health Sciences Institute, University of California, San Francisco, California, USA
(P-190) Characterizing Real-world Treatment Patterns Among Patients Hospitalized Due to sars-cov-2
Atul Butte
Favorite
Buysse, Brian

Syneos Health
(P-565) Recent Use of External Controls in Clinical Trials: A Pragmatic Literature Review
Brian Buysse
Favorite
Bylsma, Lauren

EpidStrategies
(P-203) Systematic Literature Review (SLR) of Respiratory Syncytial Virus (RSV) Burden and Health Care Utilization (HCU) Among Infants in the United States (US)
Lauren Bylsma
Favorite